EVEREST MED's Principal Shareholder Fu Wei Increases Stake by 679,000 Shares

Stock News

Jun 10

EVEREST MED (HKEX: 01952) has announced that the company's board of directors was informed by Mr. Fu Wei, a non-executive director, honorary chairman of the board, and a principal shareholder, of a recent share purchase.

Between June 8, 2026, and June 9, 2026, C-Bridge Capital, acting as a principal shareholder, acquired 679,000 ordinary shares of the company in the open market.

The total consideration for this transaction was approximately HK$18.9 million, resulting in an average price of about HK$27.90 per share.

According to statements from Mr. Fu Wei and C-Bridge Capital, the purchase was executed through on-market acquisitions and reflects their strong confidence in the company's future prospects and long-term development.

Subject to compliance with all applicable laws and regulations, Mr. Fu Wei and C-Bridge Capital have indicated that they do not rule out the possibility of further increasing their stake in the company at an appropriate time in the future.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/news/1120336233"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120336233\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120336233?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-10 07:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120336233","market":"sh","top_or_hot":-1,"title":"EVEREST MED's Principal Shareholder Fu Wei Increases Stake by 679,000 Shares","media":"Stock News","content":"<p>EVEREST MED (HKEX: 01952) has announced that the company's board of directors was informed by Mr. Fu Wei, a non-executive director, honorary chairman of the board, and a principal shareholder, of a recent share purchase.<br><br>Between June 8, 2026, and June 9, 2026, C-Bridge Capital, acting as a principal shareholder, acquired 679,000 ordinary shares of the company in the open market.<br><br>The total consideration for this transaction was approximately HK$18.9 million, resulting in an average price of about HK$27.90 per share.<br><br>According to statements from Mr. Fu Wei and C-Bridge Capital, the purchase was executed through on-market acquisitions and reflects their strong confidence in the company's future prospects and long-term development.<br><br>Subject to compliance with all applicable laws and regulations, Mr. Fu Wei and C-Bridge Capital have indicated that they do not rule out the possibility of further increasing their stake in the company at an appropriate time in the future.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EVEREST MED's Principal Shareholder Fu Wei Increases Stake by 679,000 Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEVEREST MED's Principal Shareholder Fu Wei Increases Stake by 679,000 Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-10 07:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>EVEREST MED (HKEX: 01952) has announced that the company's board of directors was informed by Mr. Fu Wei, a non-executive director, honorary chairman of the board, and a principal shareholder, of a recent share purchase.<br><br>Between June 8, 2026, and June 9, 2026, C-Bridge Capital, acting as a principal shareholder, acquired 679,000 ordinary shares of the company in the open market.<br><br>The total consideration for this transaction was approximately HK$18.9 million, resulting in an average price of about HK$27.90 per share.<br><br>According to statements from Mr. Fu Wei and C-Bridge Capital, the purchase was executed through on-market acquisitions and reflects their strong confidence in the company's future prospects and long-term development.<br><br>Subject to compliance with all applicable laws and regulations, Mr. Fu Wei and C-Bridge Capital have indicated that they do not rule out the possibility of further increasing their stake in the company at an appropriate time in the future.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1120336233","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120336233","pubTimestamp":1781046955,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"EVEREST MED (HKEX: 01952) has announced that the company's board of directors was informed by Mr. Fu Wei, a non-executive director, honorary chairman of the board, and a principal shareholder, of a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","BK1583":"高瓴概念","01952":"云顶新耀","BK1574":"生物医药B类股"},"translate_title":"EVEREST MED主要股东付伟增持67.9万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01952":1},"content_text":"EVEREST MED (HKEX: 01952) has announced that the company's board of directors was informed by Mr. Fu Wei, a non-executive director, honorary chairman of the board, and a principal shareholder, of a recent share purchase.Between June 8, 2026, and June 9, 2026, C-Bridge Capital, acting as a principal shareholder, acquired 679,000 ordinary shares of the company in the open market.The total consideration for this transaction was approximately HK$18.9 million, resulting in an average price of about HK$27.90 per share.According to statements from Mr. Fu Wei and C-Bridge Capital, the purchase was executed through on-market acquisitions and reflects their strong confidence in the company's future prospects and long-term development.Subject to compliance with all applicable laws and regulations, Mr. Fu Wei and C-Bridge Capital have indicated that they do not rule out the possibility of further increasing their stake in the company at an appropriate time in the future.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}